Asthma Week

Asthma Week

Welcome Message

Asthma is a chronic, debilitating disease of the lungs that impacts children and adults across the lifespan and throughout the world. Recent data from the Centers for Disease Control indicate that, in the United States, about one in 12 people have asthma, making it one of the most prevalent chronic diseases. Asthma is responsible for 1.5 million emergency department visits each year, significantly impacting the live of patients and costing the US approximately $56 billion each year in medical costs, lost school and work days and early deaths. In addition, despite significant advances in the clinical care of patients with asthma, their numbers continue to increase every year. Exciting new treatments are being developed by researchers and being tested in partnership with the pharmaceutical industry.

The ATS recognizes the need to disseminate such information publicly, especially to individuals with asthma and primary health care providers.  For these reasons, the ATS, its researchers, and health professionals must interface with patients and their families.  The ATS is committed to its PAR partnership with the Asthma and Allergy Foundation of America (AAFA) to ensure stakeholders see the enduring value of ongoing work and research related to asthma.

Greg P. Downey, MD

Greg P. Downey, MD
Chair, Allergy, Immunology
& Inflammation Assembly
Member, ATS Board of Directors

Charlotte Collins, JD

Charlotte Collins, JD
Vice President, Policy and Program
Asthma and Allergy Foundation of America
Member, Public Advisory Roundtable (PAR)


The Asthma and Allergy Foundation of America (AAFA), a not-for-profit organization founded in 1953, is the leading patient organization for people with asthma and allergies, and the oldest asthma and allergy patient group in the world.  AAFA is dedicated to improving the quality of life for people with asthma and allergic diseases through education, advocacy and research. Click here to learn more about AAFA.